Ethyl Indole-2-Carboxylate CAS 3770-50-1 Purity >98.5% (GC) Factory High Quality

Inkcazelo emfutshane:

Igama leKhemikhali: Ethyl Indole-2-Carboxylate

CAS: 3770-50-1

Ubunyulu: >98.5% (GC)

Imbonakalo: Okumhlophe-Kumhlophe ukuya kwiPowder etyheli

Umgangatho ophezulu, iMveliso yoRhwebo

E-Mail: alvin@ruifuchem.com

Thumela i-imeyile kuthi

Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

Ubonelelo loMvelisi ngoMgangatho oPhezulu, iMveliso yoRhwebo
Igama leMichiza: Ethyl Indole-2-Carboxylate CAS: 3770-50-1

Iipropati zeMichiza:

Igama leMchiza	Ethyl Indole-2-Carboxylate
Izithethantonye	Indole-2-Carboxylic Acid Ethyl Ester;I-Ethyl 1H-Indole-2-Carboxylate;2-Ethoxycarbonylindole
Inombolo yeCAS	3770-50-1
Inombolo yeCAT	RF-PI1481
Ubume beStokhwe	Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni
Ifomula yeemolekyuli	C11H11NO2
Ubunzima beMolekyuli	189.21
Uphawu	Ruifu Chemical

Iinkcukacha:

Into	Iinkcukacha
Imbonakalo	I-Off-White ukuya kwiPowder etyheli
Ubunyulu / Indlela yokuHlalutya	>98.5% (GC)
Indawo yokunyibilika	115.0 ~ 125.0℃
Ilahleko ekomisweni	≤0.50%
Ukungcola ngokupheleleyo	<1.50%
Umgangatho woVavanyo	Umgangatho woShishino
Ukusetyenziswa	AbaPhakathi bamayeza

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi.

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma.

Izinto eziluncedo:

FAQ:

Isicelo:

I-Ethyl Indole-2-Carboxylate (i-CAS: 3770-50-1) ibhloko yokwakha esetyenzisiweyo njenge-reactant yokulungiswa kwe-pyridazinoindole derivatives enemisebenzi ye-antimicrobial.Isetyenziswa njengama-pharmaceutical intermediates kwi-synthesis ye-angiotensin yokuguqula i-enzyme inhibitors (ACEIs).I-Reactant ukulungiselela: I-CRTH2 ye-receptor antagonists;I-Indoleamine 2,3-dioxygenase (IDO) inhibitors;I-Cannabinoid CB1 i-receptor antagonists;Iinhibitors ye-Human Reticulocyte 15-Lipoxygenase-1;I-N- (benzoylphenyl) -1H-indole-2-carboxamides njengama-antihypertriglyceridemic agents anamandla;I-antiproliferative agent echasene ne-leukemia yabantu iiseli ze-K562;I-inhibitors ye-p38 MAP kinase;I-Acetolactate synthase inhibitors.